uMI Panorama
Shanghai United Imaging Healthcare Co., Ltd. • Radiology • 07/26/2023
Device Purpose
The uMI Panorama GS is an advanced diagnostic imaging system that integrates Positron Emission Tomography (PET) with an extended 148 cm axial field of view and Computed Tomography (CT) to provide comprehensive functional and anatomical information. Its design, featuring 504 PET detector rings and specialized support systems, aims to enhance image quality, accelerate scan times, and improve diagnostic capabilities across oncology, cardiology, and neurology, including functionality for low-dose CT lung cancer screening.
Summary
The uMI Panorama GS is a diagnostic imaging system that combines Positron Emission Tomography (PET) and Computed Tomography (CT) modalities. The PET component measures the quantitative distribution of radiopharmaceuticals within the patient's body, assisting healthcare providers in assessing metabolic and physiological functions. The CT component provides diagnostic tomographic anatomical information and photon attenuation data for the scanned region. The system facilitates accurate registration and fusion of PET and CT images, offering anatomical reference for PET findings. The uMI Panorama GS model features an extended 148 cm axial field of view (FOV) PET system with 504 detector rings using LYSO scintillator material, a significant increase from the predicate device's 120 rings and 35 cm FOV. This design aims to deliver high-quality functional and anatomical images, enable faster PET/CT imaging, and improve the overall patient experience. The integrated CT system is the uCT ATLAS Astound with a 40mm detector, which can also operate independently for standalone diagnostic CT imaging. The system is intended for use by qualified healthcare professionals to aid in the detection, localization, diagnosis, staging, restaging, treatment planning, and evaluation of treatment response for a variety of diseases, inflammations, infections, and disorders, particularly in oncology, cardiology, and neurology. It also supports low-dose CT lung cancer screening for early detection of lung nodules. The device includes a patient table with a 250 kg maximum load capacity and an upgraded power supply cabinet and chiller to meet the demands of the extended PET system. Non-clinical image performance testing was conducted to verify that the uMI Panorama GS met all its design specifications and demonstrated performance characteristics similar to its predicate device.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. How does the extended 148 cm axial Field of View (FOV) of the uMI Panorama GS PET system impact total scan time and patient throughput compared to systems with shorter FOVs like the predicate device (35 cm)?; What specific advantages in diagnostic accuracy or patient management does the increased number of PET detector rings (504 vs. 120) offer in clinical practice, particularly in oncology, cardiology, and neurology?; Are there any specific radiopharmaceuticals for which the uMI Panorama GS demonstrates enhanced performance or quantitative accuracy due to its extended FOV and detector design?; How does the image reconstruction algorithm of the uMI Panorama GS account for the significantly larger dataset from the extended FOV PET, and what is its impact on image quality and processing time?; Beyond faster imaging and better patient experience, what are the quantifiable benefits of the 148 cm axial FOV in terms of lesion detectability, particularly for small or low-uptake lesions, across the indicated clinical applications?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of ML-BOM detected in AI-generated device summary.
• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.
• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.
• Not detected in AI-generated device summary: SBOM, SaaSBOM, HBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly